rs3761863

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_198578.4(LRRK2):​c.7190T>C​(p.Met2397Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.649 in 1,607,482 control chromosomes in the GnomAD database, including 342,173 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M2397I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.62 ( 29240 hom., cov: 31)
Exomes 𝑓: 0.65 ( 312933 hom. )

Consequence

LRRK2
NM_198578.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9O:1

Conservation

PhyloP100: 0.378

Publications

113 publications found
Variant links:
Genes affected
LRRK2 (HGNC:18618): (leucine rich repeat kinase 2) This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008]
LRRK2 Gene-Disease associations (from GenCC):
  • autosomal dominant Parkinson disease 8
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Genomics England PanelApp
  • Parkinson disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary late onset Parkinson disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=3.09017E-6).
BP6
Variant 12-40364850-T-C is Benign according to our data. Variant chr12-40364850-T-C is described in ClinVar as Benign. ClinVar VariationId is 308647.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.662 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRRK2NM_198578.4 linkc.7190T>C p.Met2397Thr missense_variant Exon 49 of 51 ENST00000298910.12 NP_940980.4 Q5S007Q17RV3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRRK2ENST00000298910.12 linkc.7190T>C p.Met2397Thr missense_variant Exon 49 of 51 1 NM_198578.4 ENSP00000298910.7 Q5S007

Frequencies

GnomAD3 genomes
AF:
0.616
AC:
93446
AN:
151576
Hom.:
29223
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.530
Gnomad AMI
AF:
0.668
Gnomad AMR
AF:
0.585
Gnomad ASJ
AF:
0.600
Gnomad EAS
AF:
0.469
Gnomad SAS
AF:
0.618
Gnomad FIN
AF:
0.749
Gnomad MID
AF:
0.547
Gnomad NFE
AF:
0.667
Gnomad OTH
AF:
0.609
GnomAD2 exomes
AF:
0.617
AC:
153306
AN:
248412
AF XY:
0.623
show subpopulations
Gnomad AFR exome
AF:
0.526
Gnomad AMR exome
AF:
0.496
Gnomad ASJ exome
AF:
0.591
Gnomad EAS exome
AF:
0.468
Gnomad FIN exome
AF:
0.745
Gnomad NFE exome
AF:
0.665
Gnomad OTH exome
AF:
0.630
GnomAD4 exome
AF:
0.653
AC:
950317
AN:
1455788
Hom.:
312933
Cov.:
34
AF XY:
0.653
AC XY:
473248
AN XY:
724536
show subpopulations
African (AFR)
AF:
0.522
AC:
17385
AN:
33276
American (AMR)
AF:
0.508
AC:
22566
AN:
44458
Ashkenazi Jewish (ASJ)
AF:
0.597
AC:
15528
AN:
26002
East Asian (EAS)
AF:
0.462
AC:
18269
AN:
39566
South Asian (SAS)
AF:
0.630
AC:
54223
AN:
86048
European-Finnish (FIN)
AF:
0.742
AC:
39486
AN:
53228
Middle Eastern (MID)
AF:
0.528
AC:
3034
AN:
5742
European-Non Finnish (NFE)
AF:
0.669
AC:
741223
AN:
1107376
Other (OTH)
AF:
0.642
AC:
38603
AN:
60092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
14841
29682
44522
59363
74204
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19058
38116
57174
76232
95290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.616
AC:
93512
AN:
151694
Hom.:
29240
Cov.:
31
AF XY:
0.619
AC XY:
45906
AN XY:
74138
show subpopulations
African (AFR)
AF:
0.530
AC:
21946
AN:
41394
American (AMR)
AF:
0.585
AC:
8900
AN:
15210
Ashkenazi Jewish (ASJ)
AF:
0.600
AC:
2078
AN:
3462
East Asian (EAS)
AF:
0.469
AC:
2402
AN:
5126
South Asian (SAS)
AF:
0.618
AC:
2978
AN:
4816
European-Finnish (FIN)
AF:
0.749
AC:
7916
AN:
10568
Middle Eastern (MID)
AF:
0.551
AC:
162
AN:
294
European-Non Finnish (NFE)
AF:
0.667
AC:
45250
AN:
67812
Other (OTH)
AF:
0.605
AC:
1272
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1779
3558
5338
7117
8896
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
772
1544
2316
3088
3860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.639
Hom.:
102953
Bravo
AF:
0.598
TwinsUK
AF:
0.650
AC:
2410
ALSPAC
AF:
0.665
AC:
2561
ESP6500AA
AF:
0.529
AC:
2328
ESP6500EA
AF:
0.655
AC:
5634
ExAC
AF:
0.617
AC:
74804
Asia WGS
AF:
0.529
AC:
1839
AN:
3478
EpiCase
AF:
0.653
EpiControl
AF:
0.652

ClinVar

Significance: Benign
Submissions summary: Benign:9Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Aug 30, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 26844546, 25521227, 30917570, 25378673) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 04, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal dominant Parkinson disease 8 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Leprosy, susceptibility to, 1 Other:1
Jun 10, 2022
Centro Dermatológico Federico Lleras Acosta, Hospital Universitario Centro Dermatológico Federico Lleras Acosta
Significance:confers sensitivity
Review Status:no assertion criteria provided
Collection Method:case-control

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
0.22
DANN
Benign
0.13
DEOGEN2
Benign
0.14
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.080
N
LIST_S2
Benign
0.16
T
MetaRNN
Benign
0.0000031
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
1.7
L
PhyloP100
0.38
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.53
N
REVEL
Benign
0.098
Sift
Benign
0.47
T
Sift4G
Benign
0.60
T
Polyphen
0.0
B
Vest4
0.028
MPC
0.23
ClinPred
0.00052
T
GERP RS
3.0
Varity_R
0.12
gMVP
0.54
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3761863; hg19: chr12-40758652; COSMIC: COSV54153532; API